BCAB - BioAtla to Participate in the Jefferies London Healthcare Conference | Benzinga
SAN DIEGO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that the Company's management will participate in a fireside chat and scheduled one-on-one investor meetings at the Jefferies London Healthcare Conference, to be held in London, UK November 14–16, 2023.
Format: Fireside chat and one-on-one investor meetings
Date: Wednesday, November 15, 2023
Time: 12:00 p.m. GMT
Location: London, UK
Webcast Link: Click Here
About BioAtla, Inc.
BioAtla is a global clinical-stage biotechnology company with operations in San ...